ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

This adverse event was reported 523 times

These drugs are most commonly taken by patients reporting ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME:

# Drug Count
0 CICLESONIDE 306
1 PREDNISONE 304
2 ALBUTEROL SULFATE 303
3 IPRATROPIUM BROMIDE 283
4 MONTELUKAST SODIUM 280
5 TIOTROPIUM BROMIDE 274
6 MEPOLIZUMAB 261
7 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 259
8 GLYCOPYRROLATE 197
9 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 174
See all common drugs associated with ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLYCOPYRROLATE 197 0.0349
1 ACLIDINIUM BROMIDE 146 0.0228
2 CICLESONIDE 306 0.0223
3 ABACAVIR AND LAMIVUDINE 3 0.0150
4 ACEBUTOLOL HYDROCHLORIDE 16 0.0125
5 MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN 23 0.0116
6 ZINC OXIDE OINTMENT 23 0.0115
7 ZINC OXIDE 23 0.0109
8 ABACAVIR SULFATE 101 0.0104
9 TELMISARTAN AND AMLODIPINE 1 0.0100
See all drugs enriched for association with ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 261 0.3794
1 Nitrogen Binding Agent [EPC] 23 0.0095
2 Stimulant Laxative [EPC] 102 0.0071
3 alpha-1 Adrenergic Agonist [EPC] 12 0.0027
4 Antimalarial [EPC] 27 0.0026
5 Antiprotozoal [EPC] 27 0.0025
6 Polyene Antifungal [EPC] 97 0.0024
7 Protease Inhibitor [EPC] 102 0.0023
8 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 105 0.0021
9 Leukotriene Receptor Antagonist [EPC] 57 0.0019
See all drug classes enriched for association with ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME